Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
4
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
pfizer
4
×
san diego blog main
san diego top stories
clinical trials
san francisco blog main
san francisco top stories
akcea therapeutics
biotech
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
celgene
detroit blog main
detroit top stories
drugs
fda
genentech
indiana blog main
indiana top stories
inotersen
national
onpattro
patisiran
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
starboard value
tafamidis
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
What
approved
4
×
drug
fda
alnylam
bio
disease
news
roundup
adu
afternoon
ago
akcea
alnylam’s
amyloidosis
attr
available
battle
beats
bids
biogen
companies
complicated
debilitating
depression
digital
dire
epidemic
fatty
frenzied
genetic
gets
good
group
growing
heart
help
history
known
landmark
led
Language
Current search:
pfizer
×
approved
×
" boston top stories "
×
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
